Detalhe da pesquisa
1.
Geographical and ecological analyses of multiple myeloma in Denmark: Identification of potential hotspot areas and impact of urbanisation.
Eur J Haematol
; 110(3): 289-295, 2023 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-36413106
2.
Longitudinal minimal residual disease assessment in multiple myeloma patients in complete remission - results from the NMSG flow-MRD substudy within the EMN02/HO95 MM trial.
BMC Cancer
; 22(1): 147, 2022 Feb 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-35123422
3.
Outcome data from >10 000 multiple myeloma patients in the Danish and Swedish national registries.
Eur J Haematol
; 108(2): 99-108, 2022 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-34514635
4.
Carfilzomib and dexamethasone maintenance following salvage ASCT in multiple myeloma: A randomised phase 2 trial by the Nordic Myeloma Study Group.
Eur J Haematol
; 108(1): 34-44, 2022 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-34536308
5.
Validation of the UK myeloma research alliance risk profile, a new clinical prediction model for outcome in patients with newly diagnosed multiple myeloma not eligible for autologous stem cell transplantation; a population-based study from the Danish national multiple myeloma registry.
Br J Haematol
; 193(1): 119-124, 2021 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-32515050
6.
Outcome of treatment with carfilzomib before and after treatment with daratumumab in relapsed or refractory multiple myeloma patients.
Hematol Oncol
; 39(4): 521-528, 2021 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-34342035
7.
Comorbidities in multiple myeloma and implications on survival: A population-based study.
Eur J Haematol
; 106(6): 774-782, 2021 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-33565126
8.
Direct costs of antineoplastic and supportive treatment for progressive multiple myeloma in a tax-based health system.
Future Oncol
; 17(25): 3331-3341, 2021 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-34156281
9.
Strategies to improve patient-reported outcome completion rates in longitudinal studies.
Qual Life Res
; 29(2): 335-346, 2020 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-31549365
10.
Clarithromycin added to bortezomib-cyclophosphamide-dexamethasone impairs health-related quality of life in multiple myeloma patients.
Eur J Haematol
; 102(1): 70-78, 2019 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-30230047
11.
Smoldering multiple myeloma risk factors for progression: a Danish population-based cohort study.
Eur J Haematol
; 97(3): 303-9, 2016 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-26710662
12.
Bortezomib consolidation after autologous stem cell transplantation in multiple myeloma: a Nordic Myeloma Study Group randomized phase 3 trial.
Blood
; 121(23): 4647-54, 2013 Jun 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-23616624
13.
Polymorphisms in the heparanase gene in multiple myeloma association with bone morbidity and survival.
Eur J Haematol
; 94(1): 60-6, 2015 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-24954766
14.
The clinical relevance and management of monoclonal gammopathy of undetermined significance and related disorders: recommendations from the European Myeloma Network.
Haematologica
; 99(6): 984-96, 2014 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-24658815
15.
Socioeconomic Status and Overall Survival Among Patients With Hematological Malignant Neoplasms.
JAMA Netw Open
; 7(3): e241112, 2024 Mar 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-38436954
16.
Health-related quality of life and quality-adjusted progression free survival for carfilzomib and dexamethasone maintenance following salvage autologous stem-cell transplantation in patients with multiple myeloma: a randomized phase 2 trial by the Nordic Myeloma Study Group.
J Patient Rep Outcomes
; 8(1): 15, 2024 Feb 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-38315268
17.
Vascular endothelial growth factor (VEGF) gene polymorphisms may influence the efficacy of thalidomide in multiple myeloma.
Int J Cancer
; 131(5): E636-42, 2012 Sep 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-22139971
18.
Single nucleotide polymorphisms in the promoter region of the IL1B gene influence outcome in multiple myeloma patients treated with high-dose chemotherapy independently of relapse treatment with thalidomide and bortezomib.
Ann Hematol
; 90(10): 1173-81, 2011 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-21347685
19.
The importance of a sub-region on chromosome 19q13.3 for prognosis of multiple myeloma patients after high-dose treatment and stem cell support: a linkage disequilibrium mapping in RAI and CD3EAP.
Ann Hematol
; 90(6): 675-84, 2011 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-21046104
20.
Monoclonal gammopathy of undetermined significance and risk of venous thromboembolism.
Eur J Haematol
; 86(2): 129-34, 2011 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-20942842